Best Diagnostic & Research Stocks to Buy Now (2024)Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.
Industry: Diagnostics & Research
| Ticker | Company | Exchange | Industry | Zen Score | Market Cap | Price | 1d % | EBITDA | P/E | D/E |
|---|---|---|---|---|---|---|---|---|---|---|
| STRR | STAR EQUITY HOLDINGS INC | NASDAQ | Diagnostics & Research | $14.26M | $0.90 | 0.00% | $26.87M | 0.56x | 0.16 | |
| FONR | FONAR CORP | NASDAQ | Diagnostics & Research | $109.18M | $16.27 | -1.09% | $25.65M | 10.11x | 0.32 | |
| ICLR | ICON PLC | NASDAQ | Diagnostics & Research | $26.61B | $321.80 | 1.97% | $1.62B | 38.77x | 0.81 | |
| TMO | THERMO FISHER SCIENTIFIC INC | NYSE | Diagnostics & Research | $228.66B | $599.02 | 0.71% | $11.37B | 38.28x | 1.13 | |
| IDXX | IDEXX LABORATORIES INC | NASDAQ | Diagnostics & Research | $45.30B | $548.53 | 5.26% | $1.24B | 52.59x | 1.14 | |
| ENZ | ENZO BIOCHEM INC | NYSE | Diagnostics & Research | $56.35M | $1.10 | 0.92% | $33.74M | 1.64x | 0.40 | |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL INC | NYSE | Diagnostics & Research | $11.98B | $232.56 | -0.11% | $1.00B | 27.20x | 1.22 | |
| DGX | QUEST DIAGNOSTICS INC | NYSE | Diagnostics & Research | $15.64B | $140.78 | 1.16% | $1.70B | 18.70x | 1.16 | |
| QGEN | QIAGEN NV | NYSE | Diagnostics & Research | $10.25B | $45.77 | 0.84% | $680.17M | 31.18x | 0.61 | |
| NEOG | NEOGEN CORP | NASDAQ | Diagnostics & Research | $2.88B | $13.30 | 1.60% | $188.76M | 665.00x | 0.46 | |
| SHC | SOTERA HEALTH CO | NASDAQ | Diagnostics & Research | $3.23B | $11.41 | 0.09% | $426.24M | 60.05x | 6.13 | |
| A | AGILENT TECHNOLOGIES INC | NYSE | Diagnostics & Research | $45.15B | $154.08 | 1.85% | $1.69B | 36.51x | 0.77 | |
| LAB | STANDARD BIOTOOLS INC | NASDAQ | Diagnostics & Research | $941.52M | $2.53 | -0.39% | -$76.45M | -2.50x | 0.35 | |
| FLGT | FULGENT GENETICS INC | NASDAQ | Diagnostics & Research | $675.39M | $22.57 | 1.12% | -$127.63M | -4.05x | 0.09 | |
| DHR | DANAHER CORP | NYSE | Diagnostics & Research | $195.14B | $263.46 | 1.62% | $7.54B | 44.20x | 0.56 | |
| MEDP | MEDPACE HOLDINGS INC | NASDAQ | Diagnostics & Research | $12.58B | $405.88 | 1.85% | $405.89M | 39.91x | 1.67 | |
| SERA | SERA PROGNOSTICS INC | NASDAQ | Diagnostics & Research | $275.27M | $8.43 | 0.96% | -$32.31M | -7.88x | 0.39 | |
| CSTL | CASTLE BIOSCIENCES INC | NASDAQ | Diagnostics & Research | $672.51M | $24.36 | 1.88% | -$17.87M | -21.37x | 0.14 | |
| LH | LABORATORY CORP OF AMERICA HOLDINGS | NYSE | Diagnostics & Research | $17.97B | $213.21 | 0.95% | $1.55B | 41.81x | 1.08 | |
| EXAS | EXACT SCIENCES CORP | NASDAQ | Diagnostics & Research | $9.84B | $53.34 | -1.22% | $32.77M | -40.41x | 1.04 | |
| PRE | PRENETICS GLOBAL LTD | NASDAQ | Diagnostics & Research | $72.87M | $5.97 | -1.00% | -$55.20M | -1.07x | 0.21 | |
| NTRA | NATERA INC | NASDAQ | Diagnostics & Research | $13.18B | $107.31 | 1.70% | -$311.83M | -34.39x | 0.85 | |
| RVTY | REVVITY INC | NYSE | Diagnostics & Research | $13.24B | $107.31 | 0.73% | $665.40M | 87.96x | 0.71 | |
| OLK | OLINK HOLDING AB (PUBL) | NASDAQ | Diagnostics & Research | $2.99B | $24.01 | 1.22% | -$21.35M | -88.93x | 0.18 | |
| WAT | WATERS CORP | NYSE | Diagnostics & Research | $21.46B | $361.79 | 0.78% | $979.13M | 35.43x | 2.59 | |
| TWST | TWIST BIOSCIENCE CORP | NASDAQ | Diagnostics & Research | $2.82B | $48.36 | 0.48% | -$155.32M | -14.39x | 0.26 | |
| PRPO | PRECIPIO INC | NASDAQ | Diagnostics & Research | $9.17M | $6.24 | -3.85% | -$3.37M | -1.82x | 0.30 | |
| DRIO | DARIOHEALTH CORP | NASDAQ | Diagnostics & Research | $55.36M | $1.85 | 6.94% | -$50.61M | -1.10x | 0.76 | |
| NEO | NEOGENOMICS INC | NASDAQ | Diagnostics & Research | $1.93B | $15.13 | -1.75% | $1.33M | -22.92x | 0.78 | |
| IQV | IQVIA HOLDINGS INC | NYSE | Diagnostics & Research | $42.58B | $233.69 | 1.10% | $3.27B | 31.49x | 3.19 | |
| MTD | METTLER TOLEDO INTERNATIONAL INC | NYSE | Diagnostics & Research | $32.46B | $1,519.89 | 1.59% | $1.17B | 42.40x | -21.69 | |
| BNR | BURNING ROCK BIOTECH LTD | NASDAQ | Diagnostics & Research | $84.31M | $8.23 | 2.88% | -$71.63M | -0.93x | 0.35 | |
| ACRS | ACLARIS THERAPEUTICS INC | NASDAQ | Diagnostics & Research | $84.09M | $1.18 | 0.00% | -$76.72M | -1.08x | 0.23 | |
| RDNT | RADNET INC | NASDAQ | Diagnostics & Research | $4.30B | $58.24 | 2.66% | $281.33M | 176.48x | 2.17 | |
| CDNA | CAREDX INC | NASDAQ | Diagnostics & Research | $769.80M | $14.78 | -3.02% | -$175.06M | -4.33x | 0.77 | |
| PSNL | PERSONALIS INC | NASDAQ | Diagnostics & Research | $74.27M | $1.43 | -5.92% | -$79.45M | -0.75x | 0.62 | |
| STIM | NEURONETICS INC | NASDAQ | Diagnostics & Research | $72.89M | $2.43 | 1.67% | -$19.49M | -2.56x | 2.75 | |
| XWEL | XWELL INC | NASDAQ | Diagnostics & Research | $7.70M | $1.84 | 3.37% | -$21.66M | -0.31x | 1.77 | |
| GH | GUARDANT HEALTH INC | NASDAQ | Diagnostics & Research | $3.15B | $25.75 | 4.12% | -$414.22M | -6.50x | 23.96 | |
| NDRA | ENDRA LIFE SCIENCES INC | NASDAQ | Diagnostics & Research | $3.20M | $0.29 | 0.00% | -$9.63M | -0.25x | 0.37 | |
| CHEK | CHECK-CAP LTD | NASDAQ | Diagnostics & Research | $12.52M | $2.14 | -2.28% | -$19.08M | -0.71x | 0.06 | |
| ME | 23ANDME HOLDING CO | NASDAQ | Diagnostics & Research | $282.51M | $0.59 | -4.26% | -$490.64M | -0.53x | 0.61 | |
| DMTK | DERMTECH INC | NASDAQ | Diagnostics & Research | $19.93M | $0.57 | -10.66% | -$84.05M | -0.21x | 1.58 | |
| OCX | ONCOCYTE CORP | NASDAQ | Diagnostics & Research | $39.43M | $2.95 | 1.72% | -$38.55M | -0.58x | 4.67 | |
| XGN | EXAGEN INC | NASDAQ | Diagnostics & Research | $33.18M | $1.91 | 8.52% | -$14.09M | -1.75x | 1.54 | |
| MYGN | MYRIAD GENETICS INC | NASDAQ | Diagnostics & Research | $2.23B | $24.66 | -2.76% | -$163.70M | -8.81x | 0.46 | |
| PRPH | PROPHASE LABS INC | NASDAQ | Diagnostics & Research | $98.06M | $5.14 | 1.38% | -$23.50M | -3.78x | 1.01 | |
| BIAF | BIOAFFINITY TECHNOLOGIES INC | NASDAQ | Diagnostics & Research | $21.92M | $1.88 | 0.53% | -$7.92M | -2.04x | 0.53 | |
| NOTV | INOTIV INC | NASDAQ | Diagnostics & Research | $58.18M | $2.24 | 5.66% | $19.33M | -0.81x | 2.94 | |
| AWH | ASPIRA WOMEN's HEALTH INC | NASDAQ | Diagnostics & Research | $34.61M | $2.78 | -4.14% | -$14.60M | -1.96x | -6.26 | |
| VNRX | VOLITIONRX LTD | NYSEMKT | Diagnostics & Research | $65.18M | $0.79 | 4.93% | -$33.26M | -1.71x | -2.31 | |
| MDXH | MDXHEALTH SA | NASDAQ | Diagnostics & Research | $7.68M | $2.82 | -2.26% | -$21.40M | -0.21x | -126.12 | |
| GENE | GENETIC TECHNOLOGIES LTD | NASDAQ | Diagnostics & Research | $560.93k | $2.43 | -0.41% | N/A | -0.82x | 0.76 | |
| MYNZ | MAINZ BIOMED NV | NASDAQ | Diagnostics & Research | $13.50M | $0.64 | 1.59% | -$24.62M | -0.39x | 3.74 | |
| ILMN | ILLUMINA INC | NASDAQ | Diagnostics & Research | $18.32B | $115.01 | -0.49% | -$640.00M | -14.11x | 0.75 | |
| OPK | OPKO HEALTH INC | NASDAQ | Diagnostics & Research | $940.94M | $1.35 | 3.45% | -$128.11M | -3.86x | 0.58 | |
| APDN | APPLIED DNA SCIENCES INC | NASDAQ | Diagnostics & Research | $2.91M | $2.96 | -8.07% | -$11.10M | -0.17x | -194.21 | |
| PMD | PSYCHEMEDICS CORP | NASDAQ | Diagnostics & Research | $14.92M | $2.57 | -3.02% | -$970.00k | -3.34x | 0.78 | |
| TRIB | TRINITY BIOTECH PLC | NASDAQ | Diagnostics & Research | $11.73M | $1.53 | 0.66% | -$11.25M | -0.48x | -3.48 | |
| BDSX | BIODESIX INC | NASDAQ | Diagnostics & Research | $174.90M | $1.53 | 2.01% | -$32.10M | -2.82x | -16.85 | |
| MMA | ALTA GLOBAL GROUP LTD | NYSEMKT | Diagnostics & Research | N/A | $4.90 | 12.13% | -$16.12M | -0.93x | -0.55 | |
| ISPC | ISPECIMEN INC | NASDAQ | Diagnostics & Research | $2.44M | $0.25 | 13.95% | -$9.41M | -0.19x | 0.84 | |
| TTOO | T2 BIOSYSTEMS INC | NASDAQ | Diagnostics & Research | $52.49M | $5.97 | 43.51% | -$38.59M | -0.52x | -1.66 | |
| CNTG | CENTOGENE NV | NASDAQ | Diagnostics & Research | $11.04M | $0.40 | -4.76% | -$20.95M | -0.29x | -4.05 |
Diagnostic & Research Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.